Harbour BioMed has appointed Youchen Chen as Chief Financial Officer. Chen will be based in Shanghai and Hong Kong SAR, and report directly to Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed.

Chen joined Harbour BioMed in 2023 taking on increasing responsibilities across Investor Relations, Corporate Development, Business Development, and Finance. His strategic vision and collaborative leadership have significantly contributed to key strategic transactions, global partnerships, and alliances, as well as global financial management and operations. 

In his new role, Chen will enhance shareholder value and guide Harbour BioMed through its next phase of strategic development.

Dr. Wang commented: “Chen has brought a strong strategic mindset and deep financial expertise to Harbour BioMed. His ability to lead cross-functional initiatives and drive value creation has made a significant impact across the organization. I’m confident that in his new role as Chief Financial Officer, he will continue to strengthen our financial foundation and support our long-term growth.”

Before joining Harbour BioMed, Chen served as Chief Financial Officer at a clinical-stage radiopharmaceutical startup. 

He was previously Vice President at Credit Suisse China Investment Banking and Capital Market team, advising healthcare and technology companies in Greater China on strategic and financing transactions. Chen also held multiple roles as Head of Corporate Finance at Yidu Tech and Audit Assistant Manager at KPMG.